164
Participants
Start Date
June 30, 2005
Primary Completion Date
May 31, 2009
Study Completion Date
May 31, 2011
Bevacizumab
Group A: Once every 3 weeks for 12 months Group B: Once every 3 weeks for 12 months
Cyclophosphamide
Once a day for 6 months
Methotrexate
Twice daily for the first two days of every week for 6 months
Capecitabine
"Capecitabine: 2000 mg/m2 a day, on Days 1-14 of a 21 day cycle, for at total of 6 cycles (18 weeks)~Bevacizumab: 15 mg/kg IV day 1 every 3 weeks x 1 year (17 cycles)"
University of North Carolina, Durham
Indiana University Cancer Center, Indianapolis
University of California, San Francisco, San Francisco
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
Collaborators (1)
Genentech, Inc.
INDUSTRY
Beth Israel Deaconess Medical Center
OTHER
Indiana University School of Medicine
OTHER
University of California, San Francisco
OTHER
University of North Carolina
OTHER
Harold J. Burstein, MD, PhD
OTHER